-
Mashup Score: 1Wafik S. El-Deiry: Our recent review on Targeting the SMURF2-HIF1α axis - OncoDaily - 11 hour(s) ago
Wafik S. El-Deiry: Our recent review on Targeting the SMURF2-HIF1α axis / cancer, cancer therapy, Connor Purcell, Emile Youssef, Frontiers, Gary L. Olson,
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Sami (Papacek) Mansfield: Why is muscle health so important among cancer survivers? - OncoDaily - 12 hour(s) ago
Sami (Papacek) Mansfield: Why is muscle health so important among cancer survivers? / cancer, muscle health, OncoDaily, Oncology, Sami (Papacek) Mansfield
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Why is muscle health so important among cancer survivors? – Sami (Papacek) Mansfield https://t.co/oLlyumVdIu #Health #Medi…
-
-
Mashup Score: 3
Wafik S. El-Deiry: Career opportunity at Legorreta Cancer Center / Brown University, cancer, cancer biology, fight against cancer, Global fight against
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Career opportunity at Legorreta Cancer Center – @weldeiry (@BrownUCancer) https://t.co/vDAbmxk6Dq #Health #Medicine #Cance…
-
-
Mashup Score: 2
Myeloma Paper of the Day, December 21st, suggested by Robert Orlowski / Anne J. Novak, cancer, Hyo Jin Kim, Jonas Paludo, Jordan E. Krull, Jose C. Villasboas,
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Myeloma Paper of the Day, December 21st, suggested by @Myeloma_Doc https://t.co/fi690xNA8y @pattymondello #Cancer #Mmsm…
-
-
Mashup Score: 8FDA Grants Dostarlimab Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer - OncoDaily - 1 day(s) ago
FDA Grants Dostarlimab Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer / cancer, dMMR/MSI-H Rectal Cancer, Dostarlimab, FDA, OncoDaily, Oncology,
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @OncoDailyGI: 🚨FDA Grants Dostarlimab Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer https://t.co/6PdWGU1uv4 @US_FDA #…
-
-
Mashup Score: 1Jean-Charles Soria: How FcγR engagement influences antibody efficacy, toxicity and pharmacokinetics - OncoDaily - 1 day(s) ago
Jean-Charles Soria: How FcγR engagement influences antibody efficacy, toxicity and pharmacokinetics / Alvaro Sebastian, Aurélien Marabelle, cancer,
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @OncoDailyIO: How FcγR engagement influences antibody efficacy, toxicity and pharmacokinetics - @jsoriamd https://t.co/LKn4NtCA7B #Can…
-
-
Mashup Score: 2
Vivek Subbiah: Thrilled to Share My Latest Blog with AACR / AACR, AACR Blog, cancer, Cancer research, OncoDaily, Oncology, Precision Oncology, Research, Vivek
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Thrilled to Share My Latest Blog with @AACR - @VivekSubbiah https://t.co/Hkso9QN8bd #Cancer #PrecisionOncology #CancerCare…
-
-
Mashup Score: 1
An upcoming FDA-AACR workshop on DPD deficiency testing / AACR, cancer, dihydropyrimidine dehydrogenase, DPD, DPD deficiency testing, FDA, Jennifer Gao,
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: An upcoming FDA-AACR workshop on DPD deficiency testing @AACR @AACRPres https://t.co/pBfwfveany #AACR #Cancer #FDA #OncoD…
-
-
Mashup Score: 6
Post ASH24: The Most Important MPN Studies – IACH / ASH24, cancer, IACH, Naveen Pemmaraju, OncoDaily, Oncology
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Webinar Alert❗️ Post ASH24: The Most Important MPN Studies - @TheIACH @doctorpemm https://t.co/d9nWk9XzpI #Cancer #ASH24…
-
-
Mashup Score: 2
Renuka Iyer: A big milestone in Cholangiocarcinoma care / cancer, cholangiocarcinoma, OncoDaily, Oncology, Rachna Shroff, Renuka Iyer
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @OncoDailyGI: A big milestone in Cholangiocarcinoma care - Renuka Iyer https://t.co/Iuf1DmUzqm @rachnatshroff @HH_Oncodr @ajscott40 @M…
-
RT @oncodaily: Our recent review on Targeting the SMURF2-HIF1α axis – @weldeiry (@BrownMedicine) https://t.co/vnzRr2WzYD #Health #Medicin…